127 related articles for article (PubMed ID: 28796379)
1. Review of the current medical literature and assessment of current utilization patterns regarding human papillomavirus in situ hybridization and immunohistochemistry in dermatopathology.
Litzner BR; Lee JB; Vidal CI
J Cutan Pathol; 2017 Nov; 44(11):938-943. PubMed ID: 28796379
[TBL] [Abstract][Full Text] [Related]
2. Review of the current medical literature and assessment of current utilization patterns regarding mismatch repair protein immunohistochemistry in cutaneous Muir-Torre syndrome-associated neoplasms.
Lee JB; Litzner BR; Vidal CI
J Cutan Pathol; 2017 Nov; 44(11):931-937. PubMed ID: 28749576
[TBL] [Abstract][Full Text] [Related]
3. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
[TBL] [Abstract][Full Text] [Related]
4. Utilization and utility of immunohistochemistry in dermatopathology.
Naert KA; Trotter MJ
Am J Dermatopathol; 2013 Feb; 35(1):74-7. PubMed ID: 22722468
[TBL] [Abstract][Full Text] [Related]
5. PAS and GMS utility in dermatopathology: Review of the current medical literature.
Shalin SC; Ferringer T; Cassarino DS
J Cutan Pathol; 2020 Nov; 47(11):1096-1102. PubMed ID: 32515092
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase (ALK1) immunohistochemistry in diagnostic dermatopathology; an update.
Papalas JA; Kulbacki E; Wang E
Am J Dermatopathol; 2013 Jun; 35(4):403-8; quiz 409-11. PubMed ID: 23689691
[TBL] [Abstract][Full Text] [Related]
7. Appropriate use criteria for ancillary diagnostic testing in dermatopathology: New recommendations for 11 tests and 220 clinical scenarios from the American Society of Dermatopathology Appropriate Use Criteria Committee.
; Fung MA; Vidal CI; Armbrecht EA; Andea AA; Cassarino DS; Comfere NI; Emanuel PO; Ferringer T; Hristov AC; Kim J; Lauer SR; Linos K; Missall TA; Motaparthi K; Novoa RA; Patel R; Shalin SC; Sundram U; ; Calame A; Bennett DD; Duncan LM; Elston DM; Hosler GA; Hurley YM; Lazar AJ; Lowe L; Messina J; Myles J; Plaza JA; Prieto VG; Reddy V; Schaffer A; Subtil A
J Cutan Pathol; 2022 Mar; 49(3):231-245. PubMed ID: 34536035
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry in the diagnosis of cutaneous viral infections--part I. Cutaneous viral infections by herpesviruses and papillomaviruses.
Molina-Ruiz AM; Santonja C; Rütten A; Cerroni L; Kutzner H; Requena L
Am J Dermatopathol; 2015 Jan; 37(1):1-14; quiz 12-4. PubMed ID: 25171431
[TBL] [Abstract][Full Text] [Related]
9. Infections in dermatopathology: emerging frontiers.
Abbas O; Bhawan J
Am J Dermatopathol; 2012 Dec; 34(8):789-96; quiz p.797-9. PubMed ID: 23169415
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemistry and in situ hybridization for the diagnosis and classification of squamous lesions of the anogenital region.
Pirog EC
Semin Diagn Pathol; 2015 Sep; 32(5):409-18. PubMed ID: 25862555
[TBL] [Abstract][Full Text] [Related]
11. Dermatopathology practice in ethiopia.
Gimbel DC; Legesse TB
Arch Pathol Lab Med; 2013 Jun; 137(6):798-804. PubMed ID: 23721275
[TBL] [Abstract][Full Text] [Related]
12. Detecting HPV in cutaneous lesions using anti-HPV antibody immunohistochemistry.
Wititsuwannakul J; Klump VR; McNiff JM; Ko CJ
Am J Dermatopathol; 2013 May; 35(3):327-31. PubMed ID: 23051627
[TBL] [Abstract][Full Text] [Related]
13. Molecular diagnostics-an emerging frontier in dermatopathology.
Dadzie OE; Neat M; Emley A; Bhawan J; Mahalingam M
Am J Dermatopathol; 2011 Feb; 33(1):1-13; quiz 14-6. PubMed ID: 20664321
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry in Dermatopathology: A Retrospective Study of the Most Frequently Used Antibodies.
Fuertes L; Santonja C; Kutzner H; Requena L
Am J Dermatopathol; 2016 Feb; 38(2):92-104. PubMed ID: 26825156
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostics of human papillomaviruses].
Mikysková I; Michal M
Ceska Gynekol; 2004 Nov; 69(6):510-6. PubMed ID: 15633425
[TBL] [Abstract][Full Text] [Related]
16. RNA in-situ hybridization is a practical and effective method for determining HPV status of oropharyngeal squamous cell carcinoma including discordant cases that are p16 positive by immunohistochemistry but HPV negative by DNA in-situ hybridization.
Rooper LM; Gandhi M; Bishop JA; Westra WH
Oral Oncol; 2016 Apr; 55():11-6. PubMed ID: 27016012
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnosis in dermatopathology: what makes sense, and what doesn't.
Braun-Falco M; Schempp W; Weyers W
Exp Dermatol; 2009 Jan; 18(1):12-23. PubMed ID: 19054055
[TBL] [Abstract][Full Text] [Related]
18. Dermatopathology - the link between ancillary techniques and clinical lesions.
Affolter VK
Vet Dermatol; 2017 Feb; 28(1):134-e28. PubMed ID: 27425847
[TBL] [Abstract][Full Text] [Related]
19. P16INK4A immunohistochemistry for detection of human papilloma virus-associated penile squamous cell carcinoma is superior to in-situ hybridization.
Aumayr K; Susani M; Horvat R; Wrba F; Mazal P; Klatte T; Koller A; Neudert B; Haitel A
Int J Immunopathol Pharmacol; 2013; 26(3):611-20. PubMed ID: 24067458
[TBL] [Abstract][Full Text] [Related]
20. [The detection of human papillomavirus in papillomas of the larynx and tonsils through immunohistochemistry and DNA in situ hybridization].
López Amado M; García Caballero T; Lozano Ramírez A; Labella Caballero T
An Otorrinolaringol Ibero Am; 1997; 24(3):269-80. PubMed ID: 9304351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
